英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
antiquum查看　antiquum　在百度字典中的解释百度英翻中〔查看〕
antiquum查看　antiquum　在Google字典中的解释Google英翻中〔查看〕
antiquum查看　antiquum　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • DUPIXENT® (dupilumab) For Eosinophilic Esophagitis
    Learn more about DUPIXENT® (dupilumab), the first FDA-approved biologic to treat eosinophilic esophagitis (EoE) in adult and pediatric patients aged 1 year and older who weigh at least 33lb (15kg) Serious side effects can occur Please see Important Safety Information and Prescribing Information and Patient Information on website
  • Biologics in the Treatment of Eosinophilic Esophagitis: Ready . . .
    Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including dysphagia and food impaction 1,2 The incidence and prevalence of EoE are rising and untreated disease can lead to significant esophageal stenosis 2,3 Standard treatments include proton-pump inhibitors (PPIs), swallowed topical
  • Current state of biologics in treating eosinophilic esophagitis
    Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if left untreated This review focuses on biologics therapy in EoE
  • ACG Releases Updated EoE Guideline - gastroendonews. com
    For treatments, for the first time, this guideline recommends a biologic for treatment of EoE: the FDA-approved agent dupilumab Because these are evidence-based guidelines, the recommendation is in line with the data in the approval studies
  • Is Dupixent Fda Approved For Eosinophilic Esophagitis
    Its designation as the first biologic therapy approved for EoE in both adults and children highlights its critical role in managing the condition Dupixent is recognized as a groundbreaking treatment option, ensuring that younger patients now have access to a specialized therapy designed to alleviate their suffering from EoE
  • Biologics for Eosinophilic Esophagitis: Are They Right for You?
    Wondering if you should take a biologic medication to treat eosinophilic esophagitis? Here’s what you should know about this innovative drug class
  • Efficacy of Biological and Steroid Therapies in Adolescent . . .
    All evaluated therapies except etrasimod achieved histologic remission, while only dupilumab, cendakimab, BOS, and BOT were associated with symptomatic improvement in EoE, highlighting dissociations between histologic and symptomatic responses Most corticosteroid trials were short-term and lacked direct comparisons with biologics Robust head-to-head trials are needed to define optimal
  • Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 . . .
    In the LIBERTY EoE TREET trial, a phase 3 trial involving adult and adolescent patients with eosinophilic esophagitis refractory to proton-pump inhibitor therapy (all the patients were ≥12 years
  • Eosinophilic Esophagitis Treatment: Your FAQs - Healthline
    Eosinophilic esophagitis is a condition that causes inflammation in the esophagus and can lead to difficulty swallowing Treatment options include medications, esophageal dilation, and dietary
  • Full article: Biologics for eosinophilic oesophagitis: a . . .
    Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred research into targeted biological therapies, while the conclusive therapeutic efficacy of biologics remains uncertain In this review, we conducted a meta-analysis of all RCTS of biologics in the treatment of EoE to evaluate their





中文字典-英文字典  2005-2009